Study sponsor: AstraZeneca Pharmaceuticals LP

Location: Enrolled participants do not need to travel.

Purpose of study:

Purpose of study: The ANCHOR asthma clinical trial is being done by AstraZeneca to assess how well AIRSUPRA reduces severe asthma attacks in adults. AIRSUPRA is an FDA approved rescue inhaler that combines two common asthma medicines (albuterol and budesonide) into a single inhaler that will help treat symptoms and help prevent asthma attacks. Albuterol helps to relax the smooth muscles of the airways, causing the airways to widen, leading to easier breathing. Budesonide helps to decrease inflammation in the lungs.

Recruitment for this study has concluded. If you are a current participant, you can contact the study by phone at 952-967-6910 or email at AnchorStudy@HealthPartners.com

Study Contact:
(952) 967-6910
AnchorStudy@HealthPartners.com